Back to Companies
Veraxa Biotech AG - Post de-SPAC
VRXANasdaqCIK: 0002079109
Veraxa Biotech AG - Post de-SPAC (VRXA) shows 11 recent insider filings from 9 insiders, with all of them on the buy side. With $82.7K in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $82.7K). Baumann Oliver Rolf (Director) is the most active by dollar volume, and the single largest transaction was $75.0K by Baumann Oliver Rolf. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$82.7K
Purchases
$82.7K
Sales
$0
Unique Insiders
9
Recent Insider Trades
11 loaded
| Sep 14 | VRXA Veraxa Biotech AG - Post de-SPAC | Willener Raju Sudir | Chief Financial Officer | Other | $0 |
| Aug 31 | VRXA Veraxa Biotech AG - Post de-SPAC | Antz Christoph Rudiger | Chief Executive Officer, Director | Buy | $7.7K |
| Aug 31 | VRXA Veraxa Biotech AG - Post de-SPAC | Baumann Oliver Rolf | Director | Buy | $75.0K |
| Aug 20 | VRXA Veraxa Biotech AG - Post de-SPAC | von Halem Carl | Interim CFO | Other | $0 |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Buergermeister Torsten Georg Friedrich | Chief Financial Officer | Other | $0 |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Schwer Heinz | Chief Business Officer | Other | $0 |
| Jun 10 | VRXA Veraxa Biotech Holding AG | Gruninger Marc | Director | Other | $0 |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Hosseinion Warren | Director | Other | $0 |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Antz Christoph Rudiger | Chief Executive Officer, Director | Other | $0 |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Baumann Oliver Rolf | Director | Other | $0 |
| Jun 10 | VRXA Veraxa Biotech Holding AG | Ziegler Christoph Samuel | Director | Other | $0 |
11 filings